<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">31277860</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>30</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>12</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0072-9752</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>160</Volume>
            <PubDate>
              <Year>2019</Year>
            </PubDate>
          </JournalIssue>
          <Title>Handbook of clinical neurology</Title>
          <ISOAbbreviation>Handb Clin Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Sleep-wake physiology.</ArticleTitle>
        <Pagination>
          <StartPage>359</StartPage>
          <EndPage>370</EndPage>
          <MedlinePgn>359-370</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/B978-0-444-64032-1.00023-0</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">B978-0-444-64032-1.00023-0</ELocationID>
        <Abstract>
          <AbstractText>This chapter presents hypotheses on the mechanisms responsible for the succession of the three vigilance states, namely waking, nonrapid eye movement (non-REM) (slow-wave sleep-SWS), and REM sleep (paradoxical sleep-PS). It can be proposed that waking is induced by the activity of multiple waking systems, including the serotonergic, noradrenergic, cholinergic, and hypocretin systems. At the onset of sleep, the SWS-active neurons are activated by the circadian clock localized in the suprachiasmatic nucleus and a hypnogenic factor, adenosine, which progressively accumulates in the brain during waking. A number of studies support the hypothesis that SWS results from the activation of GABAergic neurons localized in the ventrolateral preoptic nucleus. However, additional GABAergic systems have been described, localized in the parafacial, accumbens, and reticular thalamic nuclei, and these are also presented. In addition, the chapter discusses the fact that a large body of data strongly suggests that the switch from SWS to PS is due to the interaction of multiple populations of glutamatergic and GABAergic neurons localized in the posterior hypothalamus and the brainstem.</AbstractText>
          <CopyrightInformation>Copyright © 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Luppi</LastName>
            <ForeName>Pierre-Hervé</ForeName>
            <Initials>PH</Initials>
            <AffiliationInfo>
              <Affiliation>Lyon Neuroscience Research Center, Lyon, France. Electronic address: luppi@sommeil.univ-lyon1.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fort</LastName>
            <ForeName>Patrice</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Lyon Neuroscience Research Center, Lyon, France.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Netherlands</Country>
        <MedlineTA>Handb Clin Neurol</MedlineTA>
        <NlmUniqueID>0166161</NlmUniqueID>
        <ISSNLinking>0072-9752</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>JL5DK93RCL</RegistryNumber>
          <NameOfSubstance UI="D008550">Melatonin</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D059330" MajorTopicYN="N">GABAergic Neurons</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008550" MajorTopicYN="N">Melatonin</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012890" MajorTopicYN="N">Sleep</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012894" MajorTopicYN="N">Sleep Stages</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014851" MajorTopicYN="N">Wakefulness</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Acetylcholine</Keyword>
        <Keyword MajorTopicYN="N">Adenosine</Keyword>
        <Keyword MajorTopicYN="N">Brainstem</Keyword>
        <Keyword MajorTopicYN="N">GABA</Keyword>
        <Keyword MajorTopicYN="N">Glycine</Keyword>
        <Keyword MajorTopicYN="N">Histamine</Keyword>
        <Keyword MajorTopicYN="N">Hypocretin</Keyword>
        <Keyword MajorTopicYN="N">Melanin concentrating hormone</Keyword>
        <Keyword MajorTopicYN="N">Muscle atonia</Keyword>
        <Keyword MajorTopicYN="N">Noradrenaline</Keyword>
        <Keyword MajorTopicYN="N">Orexin</Keyword>
        <Keyword MajorTopicYN="N">Serotonin</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>12</Month>
          <Day>31</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">31277860</ArticleId>
        <ArticleId IdType="doi">10.1016/B978-0-444-64032-1.00023-0</ArticleId>
        <ArticleId IdType="pii">B978-0-444-64032-1.00023-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
